Suppliers / Suzhou Ryway Biotech

Suzhou Ryway Biotech

Updated 9 July 2026

Suzhou Ryway Biotech is an API manufacturer. It holds 30 active US drug master files.

30
active US DMFs
0
valid CEPs
0
registered plants
0
filings across 0 regulators

What they file, and where

Molecule Regulators Docs
(21R)-Argatroban US FDA 1
Baloxavir Marboxil US FDA 1
Carbimazole US FDA 1
Ceftaroline Fosamil US FDA 1
Distigmine US FDA 1
Dolutegravir US FDA 1
Dotinurad US FDA 1
Ethacridine US FDA 1
Flurbiprofen US FDA 1
Iguratimod US FDA 1
Show all 30 molecules on file
Indobufen US FDA 1
Iodixanol US FDA 1
Iohexol US FDA 1
Iomeprol US FDA 1
Iopamidol US FDA 1
Iopromide US FDA 1
Ioversol US FDA 1
Loxoprofen US FDA 1
Mesna US FDA 1
Metaraminol US FDA 1
Methimazole US FDA 1
Polaprezinc US FDA 1
Propylthiouracil US FDA 1
Semaglutide US FDA 1
Sofosbuvir US FDA 1
Sugammadex US FDA 1
Thymalfasin US FDA 1
Tiopronin US FDA 1
Tirzepatide US FDA 1
Voglibose US FDA 1

Also appears on these molecule pages

Comparing suppliers?

Choose your molecules and target markets. Suzhou Ryway Biotech comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability